Upstream Medical Technologies, which is developing novel biomarkers for heart disease, has raised $2 million in its latest capital round to take it from discovery to commercial development.
The $2m investment was led by existing deep tech investor Pacific Channel and included $262,500 from new
Want to read more? It's easy.
Choose your best value subscription option
Get instant access to this article now as part of our FREE two week trial.
Get two weeks free access to NBR’s Premium Online Subscription, which includes full access to all of NBR’s great content on any device.
